Ecate, Inc.
Los Angeles, CA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3686 Barham Blvd h301, Los Angeles, CA 90068, USA
- Website
- ecate.tech
- Founded
- 2020
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Southern California | U41NS129514 | $29,138 |
Similar vendors
About the company
Ecate, Inc. is a corporate entity registered in SAM.gov since August 2020, functioning as a small disadvantaged business and for-profit organization located in Los Angeles, California. The company specializes in developing advanced neural interface technologies with a primary focus on medical innovation, particularly in the realm of neurological rehabilitation and neural connectivity restoration for patients with spinal cord injuries. While specific details about the company's complete background are limited, its federal grant award history reveals a clear commitment to developing cutting-edge biomedical technologies that aim to address complex neurological challenges.
Through federal grant awards from the National Science Foundation, specifically the Small Business Technology Transfer (STTR) and Small Business Innovation Research (SBIR) programs, Ecate, Inc. has consistently pursued innovative neural digitization and stimulation technologies. The company has been awarded two significant prime federal grants totaling approximately $528,861, both centered on developing intraspinal stimulator systems designed to restore sensation and motor control for spinal cord injury patients. Their most recent NSF Technology, Innovation, and Partnerships grant (Award ID: 2403910) focuses on creating a novel intraspinal stimulator system with nanopatterned electrodes and custom CMOS chips to deliver spatially selective electrical stimulation. Additionally, the company has engaged in a sub-grant award with the University of Southern California's HORNET Center for Autonomic Nerve Recording and Stimulation Systems, further demonstrating its collaborative approach to advancing neural interface technologies. The grants specifically target rehabilitating paralysis-related conditions, with potential applications in addressing neurogenic bladder, mobility issues, and restoring communication between patients' bodies and brains.
Quick answers
Is Ecate, Inc. registered in SAM.gov?
Yes. Ecate, Inc.'s SAM.gov registration is active through January 25, 2027.
What is Ecate, Inc.'s CAGE code?
Ecate, Inc.'s CAGE code is 8RAH5, and its Unique Entity ID (UEI) is H87NNXN7AHJ3.
What is Ecate, Inc.'s most recent federal award?
Ecate, Inc.'s most recent federal grant award is Sttr phase I: high-resolution, spatially selective intraspinal stimulator to restore sensation in spinal cord injury… (2403910), from National Science Foundation, on June 15, 2024.
On GovTribe
See Ecate, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors